CIK 0001811115 · <br>Emerging growth company
Renalytix plc
Sign in to watch- Ticker
- RENXF
- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- FY end
- Jun 30
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 29 2071 0570
- Business address
- FINSGATE, 5-7 CRANWOOD STREET, LONDON, United Kingdom
- Former names
- Renalytix AI plc
Securities
- RENXF Common stock OTC
- RNLXY American depositary shares OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-01 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 10% owner | Other acquisition | +13,366,750 | $0.12 | $1.6M | 32,683,998 |
| 2024-06-11 | Jung Joel R Interim Chief Financial Office | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-04-24 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 10% owner | Other acquisition | +9,360,374 | $0.25 | $2.3M | 19,317,248 |
| 2023-11-20 | Coste Catherine Director | Grant or award · Employee Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2023-11-20 | LEVANGIE DANIEL J Director | Grant or award · Employee Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2023-11-20 | Parikh Chirag R. Director | Grant or award · Employee Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2023-11-20 | MILLS CHRISTOPHER Director | Grant or award · Employee Stock Option (right to buy) | +95,000 | 95,000 | ||
| 2023-11-20 | Doran Howard JR Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2023-07-10 | MCLAIN THOMAS H President | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2023-07-06 | Donovan Michael J. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +85,731 | 85,731 | ||
| 2023-07-06 | Coste Catherine Director | Grant or award · Employee Stock Option (right to buy) | +190,000 | 190,000 | ||
| 2023-07-06 | McCullough James Renwick Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +875,017 | 875,017 | ||
| 2023-07-06 | MCLAIN THOMAS H President | Grant or award · Employee Stock Option (right to buy) | +394,486 | 394,486 | ||
| 2023-07-06 | Fleming Fergus Chief Technical Officer | Grant or award · Employee Stock Option (right to buy) | +352,902 | 352,902 | ||
| 2023-07-06 | Sterling O. James Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +575,160 | 575,160 |
Page 1 of 1 · 15 trades